Favorites Sign in
  1. Home
  2. Companies
  3. Stock Cidara Therapeutics
Cidara Therapeutics logo

Cidara Therapeutics CDTX

report update icon

Quarterly report 2025-Q3
added 05-16-2026

Country

 usaUSA

IPO year

 2015

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBAL

Shares

 6.35 M

Market Cap[1]

 $ 1.41 B

EBITDA (LTM)

 -

P/E (LTM)

 -

P/S (LTM)

 -

EPS (LTM)

 -

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Kaleido Biosciences Kaleido Biosciences
KLDO
 		- -3.69 % $ 12.4 M Nasdaq Global Select Market usaUSA
VBI Vaccines VBI Vaccines
VBIV
 		- -50.87 % $ 1.09 M Nasdaq Capital Market usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
 		- - $ 1.2 B Nasdaq Capital Market usaUSA
Decibel Therapeutics Decibel Therapeutics
DBTX
 		- - $ 123 M Nasdaq Global Select Market usaUSA
NuCana plc NuCana plc
NCNA
 		$ 1.02 0.99 % $ 11.5 B Nasdaq Global Select Market britainBritain
PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals
PHAS
 		- 7.4 % $ 6.29 M Nasdaq Global Market usaUSA
Provention Bio Provention Bio
PRVB
 		- - $ 2.37 B Nasdaq Global Select Market usaUSA
IVERIC bio IVERIC bio
ISEE
 		- - $ 5.51 B Nasdaq Global Select Market usaUSA
Reata Pharmaceuticals Reata Pharmaceuticals
RETA
 		- - $ 6.29 B Nasdaq Global Market,SPB usaUSA
ObsEva SA ObsEva SA
OBSV
 		- -15.52 % $ 10.5 M Nasdaq Global Select Market schweizSchweiz
PolarityTE PolarityTE
PTE
 		- -0.82 % $ 1.78 M Nasdaq Capital Market usaUSA
Kronos Bio Kronos Bio
KRON
 		- 1.49 % $ 50.8 M Nasdaq Global Select Market usaUSA
Landos Biopharma Landos Biopharma
LABP
 		- 0.58 % $ 144 M Nasdaq Global Market usaUSA
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
 		- -0.04 % $ 2.62 B NYSE usaUSA
Poseida Therapeutics Poseida Therapeutics
PSTX
 		- - $ 857 M Nasdaq Global Select Market usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		- - $ 231 M Nasdaq Global Market usaUSA
Trevena Trevena
TRVN
 		- -46.58 % $ 31.8 M Nasdaq Capital Market usaUSA
Immunovant Immunovant
IMVT
 		$ 29.9 2.96 % $ 5.45 B Nasdaq Global Select Market usaUSA
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
 		- -45.12 % $ 2.85 M Nasdaq Global Select Market usaUSA
Oncorus Oncorus
ONCR
 		- -8.54 % $ 3.19 M Nasdaq Global Market usaUSA
Y-mAbs Therapeutics Y-mAbs Therapeutics
YMAB
 		- - $ 382 M Nasdaq Global Select Market,SPB usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
 		- -2.99 % $ 2.47 M NYSE American usaUSA
InMed Pharmaceuticals InMed Pharmaceuticals
INM
 		$ 1.75 4.17 % $ 7.29 M Nasdaq Capital Market canadaCanada
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
 		- - $ 23.9 M Nasdaq Global Select Market usaUSA
Acer Therapeutics Acer Therapeutics
ACER
 		- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Satsuma Pharmaceuticals Satsuma Pharmaceuticals
STSA
 		- -0.9 % $ 36.5 M Nasdaq Global Market usaUSA
Anavex Life Sciences Corp. Anavex Life Sciences Corp.
AVXL
 		$ 1.25 4.58 % $ 107 M Nasdaq Capital Market usaUSA
SpringWorks Therapeutics SpringWorks Therapeutics
SWTX
 		- - $ 3.48 B Nasdaq Global Select Market,SPB usaUSA
Metacrine Metacrine
MTCR
 		- - $ 24.2 M Nasdaq Global Select Market usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
 		- -0.13 % $ 3.73 B Nasdaq Global Select Market,SPB usaUSA
Ionis Pharmaceuticals Ionis Pharmaceuticals
IONS
 		$ 40.14 -0.69 % $ 6.42 B Nasdaq Global Select Market,SPB usaUSA
Infinity Pharmaceuticals Infinity Pharmaceuticals
INFI
 		- -46.98 % $ 3.57 M Nasdaq Global Select Market usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
 		- 31.87 % $ 1.61 M Nasdaq Global Select Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		- - $ 7.46 M Nasdaq Global Market israelIsrael
Evelo Biosciences Evelo Biosciences
EVLO
 		- -14.46 % $ 27.9 M Nasdaq Global Select Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Morphic Holding Morphic Holding
MORF
 		- - $ 2.42 B Nasdaq Global Market usaUSA
Novan Novan
NOVN
 		- -24.84 % $ 2.64 M Nasdaq Capital Market usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
 		- -15.0 % $ 3.04 M Nasdaq Global Select Market usaUSA
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
 		- -9.21 % $ 2.55 M Nasdaq Global Market usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
BELLUS Health BELLUS Health
BLU
 		- - $ 2.47 B Nasdaq Global Select Market canadaCanada
bluebird bio bluebird bio
BLUE
 		- - $ 546 M Nasdaq Global Select Market,SPB usaUSA
Intra-Cellular Therapies Intra-Cellular Therapies
ITCI
 		- - $ 13.6 B Nasdaq Global Select Market,SPB usaUSA
IGM Biosciences IGM Biosciences
IGMS
 		- - $ 76.9 M Nasdaq Global Select Market,SPB usaUSA
Marinus Pharmaceuticals Marinus Pharmaceuticals
MRNS
 		- - $ 29.6 M Nasdaq Global Select Market usaUSA
Merrimack Pharmaceuticals Merrimack Pharmaceuticals
MACK
 		- - $ 216 M Nasdaq Global Market usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
 		- - $ 35.4 M Nasdaq Capital Market usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
 		- -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
 		- - $ 728 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.